rasagiline has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, Z; Abu-Saleh, N; Armaly, Z; Awad, H; Heyman, SN; Holman, J; Ichimura, T; Kaballa, A; Karram, T; Khamaisi, M | 1 |
| Adam, D; Amit, T; Awad, H; Bachner-Hinenzon, N; Bar-Am, O; Barac, Y; Binah, O; Blum, S; Ertracht, O; Frolov, L; Liani, E; Ovcharenko, E; Youdim, M | 1 |
2 other study(ies) available for rasagiline and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury.
Topics: Acute Kidney Injury; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Indans; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spin Labels; Stress, Physiological | 2014 |
The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion.
Topics: Animals; Cardiotonic Agents; Caspase 3; Caspase 9; Cells, Cultured; Cytochromes c; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indans; Male; Membrane Potentials; Mitochondria; Myocardial Infarction; Myocardium; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2011 |